The Pharmacogenomics Journal - Table of Contents alert Volume 18 Issue 5

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 18, Issue 5 In this issue News Article Also new AOP News Pharmacogenetics of ugt genes in North African populations M. Gaibar, A. Novillo, A. Romero-Lorca, M. E. Esteban & A. Fernández-Santander The Pharmacogenomics Journal 2018 18 :609 - 612; July 31, 2018; 10.1038/s41397-018-0034-4 Abstract | Full Text Article Genotype, phenotype, and medication recommendation agreement among commercial pharmacogenetic-based decision support tools Chad A. Bousman & Boadie W. Dunlop The Pharmacogenomics Journal 2018 18 :613 - 622; May 25, 2018; 10.1038/s41397-018-0027-3 Abstract | Full Text Potential role of PIN1 genotypes in predicting benefit from oxaliplatin-based and irinotecan-based treatment in patients with metastatic colorectal cancer Mitsukuni Suenaga, Marta Schirripa, Shu Cao, Wu Zhang, Dongyun Yang et al. The Pharmacogenomics Journal 2018 18 :623 - 632; June 21, 2018; 10.1038/s41397-018-0030-8 Abstract | Full Text Associations between genetic polymorphisms of membrane transporter genes and prognosis after chemotherapy: meta-analysis and finding from Seoul Breast Cancer Study (SEBCS) Ji-Eun Kim, Jaesung Choi, JooYong Park, Chulbum Park, Se Mi Lee et al. The Pharmacogenomics Journal 2018 18 :633 - 645; April 04, 2018; 10.1038/s41397-018-0016-6 Abstract | Full Text Frequency of vitamin K oxidoreductase complex subunit-1 (VKORC1) polymorphisms and warfarin dose management in patients with venous thromboembolism Pinar Akin Kabalak, Ismail Savas, Nejat Akar, Nalan Demir & Yonca Egin The Pharmacogenomics Journal 2018 18 :646 - 651; August 10, 2018; 10.1038/s41397-018-0037-1 Abstract | Full Text The rs2108622 polymorphism is related to the early risk of ischemic stroke in non-valvular atrial fibrillation subjects under oral anticoagulation L. Colàs-Campàs, J. L. Royo, M. V. Montserrat, C. Marzo, J. Molina-Seguín et al. The Pharmacogenomics Journal 2017 18 :652 - 656; December 22, 2017; 10.1038/s41397-017-0007-z Abstract | Full Text Genome-wide association study of response to tumour necrosis factor inhibitor therapy in rheumatoid arthritis Jonathan Massey, Darren Plant, Kimme Hyrich, Ann W. Morgan, Anthony G. Wilson et al. The Pharmacogenomics Journal 2018 18 :657 - 664; August 31, 2018; 10.1038/s41397-018-0040-6 Abstract | Full Text The phosphatidylinositide 3-kinase (PI3K) signaling pathway is a determinant of zileuton response in adults with asthma Amber Dahlin, Weiliang Qiu, Augusto A. Litonjua, John J. Lima, Mayumi Tamari et al. The Pharmacogenomics Journal 2018 18 :665 - 677; January 03, 2018; 10.1038/s41397-017-0006-0 Abstract | Full Text Polymorphisms in cytochrome P450 are associated with extensive efavirenz pharmacokinetics and CNS toxicities in an HIV cohort in Botswana Marijana Vujkovic, Scarlett L. Bellamy, Athena F. Zuppa, Marc R. Gastonguay, Ganesh S. Moorthy et al. The Pharmacogenomics Journal 2018 18 :678 - 688; June 01, 2018; 10.1038/s41397-018-0028-2 Abstract | Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to The Pharmacogenomics Journal. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. Nature is part of Springer Nature. © 2018 Springer Nature Limited. All rights reserved.